EMN vs LMAT · P/E 21, rev $9.38B vs P/E 35, rev $136.9M
Eastman Chemical Company (EMN) versus LeMaitre Vascular Inc (LMAT) — a side-by-side from cached financials, not a winner call.
Eastman Chemical Company (EMN) is a specialty chemicals company listed on US.
LeMaitre Vascular Inc (LMAT) is a medical instruments & supplies company listed on US.
Latest reported EMN revenue for 2024-12-31 was $9.38B. Net income was $908.0M. Revenue was up 1.9% from 2023-12-31 to 2024-12-31. EMN currently screens at market cap $8.21B and trailing P/E 20.8.
Latest reported LMAT revenue for 2026-06-30 was $136.9M. Net income was $32.7M. LMAT currently screens at market cap $2.16B and trailing P/E 34.8.
EMN currently screens at market cap $8.21B and trailing P/E 20.8. LMAT currently screens at market cap $2.16B and trailing P/E 34.8.
Not investment advice. Open the EMN and LMAT stock pages for the full models.
Not investment advice.